Automation System Improves Operational Insight

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-02-2013
Volume 37
Issue 11

Automation System Improves Operational Insight

The Foxboro Evo Process automation system uses a high-speed, fault-tolerant, and cyber-secure hardware platform that is an upgrade from the Foxboro I/A Series; the system integrates Triconex safety technology. The system uses a component object-based platform that allows users to perform upgrades at their own pace without halting operations. Additionally, its new applications streamline and contextualize the information plant personnel need to make business decisions. The Foxboro Evo system includes a new high-speed controller, field device manage

Invensys

Articles in this issue
Report from Brazil November 2013
Report from Brazil November 2013
Applying Catalysis to Optimize API Synthesis
Applying Catalysis to Optimize API Synthesis
Predicting Long-Term Storage Stability of Therapeutic Proteins
NEW_Keitel_passport-photo-827678-1408529973903.jpg
Control of Elemental Impurities
Automation System Improves Operational Insight
Automation System Improves Operational Insight
Eric_Langer_Headshot-827773-1408529855530.jpg
Disposable Applications in Demand by Biopharma
Solvent-Free Coating of Traditional and User-Friendly Dosage Forms
Solvent-Free Coating of Traditional and User-Friendly Dosage Forms
Wechsler_Jill-827676-1408529978030.jpg
Congress Revises Rules for Drug Compounding and Supply-Chain Security
Can Pharma Defy Gravity at the Patent Cliff?
Can Pharma Defy Gravity at the Patent Cliff?
NEW_Troubleshooting-827681-1408529966388.jpg
Defining and Presenting Overkill Cycle Validation
Preparing for Patent Expiry
Wireless Network Monitors Air Cooled Heat Exchanger
Wireless Network Monitors Air Cooled Heat Exchanger
Database Improves Process Efficiency
Database Improves Process Efficiency
System Links Packaging Operations
System Links Packaging Operations
Milmo_Sean-827677-1408529975535.jpg
European Union Introduces GMPs for Excipients
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Sanofi Grows Antibody Production in France with €40 Million Investment

Feliza Mirasol
November 22nd 2024
Article

Sanofi will use this investment to increase its antibody bioproduction at its site in Lyon Gerland, France.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Three New European Facilities Established by BioPharmaSpec for R&D

Feliza Mirasol
November 21st 2024
Article

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
November 14th 2023
Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

Feliza Mirasol
November 16th 2024
Article

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.